GETTING MY RAW MATERIALS TO WORK

“The current circumstance has uncovered some structural weaknesses from the EU’s medicines supply chain plus a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She recommended that supply chain challenges be resolved within an EU pharmaceutical strategy expected to generally